2012
DOI: 10.1016/j.knee.2011.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of early-stage osteochondral defect repair using a biphasic scaffold based on a collagen–glycosaminoglycan biopolymer in a caprine model

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
64
0
1

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
2
2

Relationship

1
8

Authors

Journals

citations
Cited by 80 publications
(66 citation statements)
references
References 30 publications
1
64
0
1
Order By: Relevance
“…Its composition is based on a collagen type-I hydroxyapatite gradient. MaioRegen® has demonstrated throughout its clinical studies that its technique is safe and that the clinical results in the short-and medium-term follow-up are efective in a large population of patients [144][145][146][147][148], even atributed beter results than other commercial scafolds ChondroMimetic TM [149] and TruFit CB TM [11,[150][151][152]. Despite the encouraging in vitro results of a wide variety of osteochondral scafolds, most are in the early stages of development.…”
Section: The Eicacy and Safety Of Diferent Treatments Of Cartilage Inmentioning
confidence: 99%
“…Its composition is based on a collagen type-I hydroxyapatite gradient. MaioRegen® has demonstrated throughout its clinical studies that its technique is safe and that the clinical results in the short-and medium-term follow-up are efective in a large population of patients [144][145][146][147][148], even atributed beter results than other commercial scafolds ChondroMimetic TM [149] and TruFit CB TM [11,[150][151][152]. Despite the encouraging in vitro results of a wide variety of osteochondral scafolds, most are in the early stages of development.…”
Section: The Eicacy and Safety Of Diferent Treatments Of Cartilage Inmentioning
confidence: 99%
“…For example, collagen-glycosaminoglycan phosphate biphasic scaffold were evaluated in caprine femoral condyle and lateral trochlear sulcus osteochondral defects model. After 26 weeks of implantation, both scaffolds provide indications of structural repair [41] .…”
Section: Introductionmentioning
confidence: 99%
“…The goal of these strategies is to use cells, scaffolds and growth factors to regenerate the damaged tissue and thus provide long term relief to the patient (2). While numerous advances have been made in the design of multiphasic scaffolds (3)(4)(5), cell culture protocols (6,7) and growth factor releasing materials (8,9), a number of issues still exist which limit the widespread implementation of these techniques. One of the most prominent of these is promoting the formation of stable bone and cartilage within the osseous and chondral regions of the defect respectively.…”
Section: Introductionmentioning
confidence: 99%